Clinical trials recruiting in Leverkusen, Germany
6
Recruiting trials
9
Conditions
Phase breakdown
Phase 3 3Not applicable 3
Conditions recruiting in Leverkusen, Germany
Recruiting trials in Leverkusen, Germany
- NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
- PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
- Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
- Register Schweres Asthma - German Asthma Net e.V.
- Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Common questions
How many clinical trials are recruiting in Leverkusen, Germany?
6 recruiting trials have at least one study site in Leverkusen, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.